QKI and non-small cell lung carcinoma: From these experiments it could be inferred that the ESYT2 splicing switch due to loss of QKI expression in NSCLC causes a cytoskeletal redistribution that has been related to endothelial infiltration and metastasis; and inhibition of endocytosis, which is typical in highly proliferative tumor cells [223].